Abstract
Danshen, also known as Salvia miltiorrhiza, is a medicinal herb used in traditional Chinese medicine. Its potential impact on endometrial cancer has not been thoroughly investigated. This study aimed to examine the effect of dihydroisotanshinone I (DT), a compound found in Danshen, on the viability of ARK1 and ARK2 endometrial cancer cells and its mechanisms. The results showed that 10 μM DT inhibited cell viability of ARK1 and ARK2 cells by inducing apoptosis and ferroptosis, which was achieved by blocking the expression of GPX4. In vivo experiments using a xenograft nude mouse model indicated that DT treatment significantly reduced tumor volume without causing any adverse effects. These findings suggest that DT may be a potential therapeutic agent for inhibiting endometrial cancer cell viability, but further research is needed to confirm these results.
Original language | English |
---|---|
Article number | e21652 |
Journal | Heliyon |
Volume | 9 |
Issue number | 11 |
DOIs | |
State | Published - 11 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors
Keywords
- apoptosis
- Dihydroisotanshinone I
- Endometrial cancer
- ferroptosis
- GPX4